Capstone Investment Advisors »

Intellia Therapeutics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 61k 20.55
2024-06-30 $1.3M 60k 22.38
2023-12-31 $1.8M 59k 30.49
2023-09-30 $1.6M 49k 31.62
2023-06-30 $455k 11k 40.78

More positions owned by Capstone Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Amazon Call Option (AMZN)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl C Call Option (GOOG)
Broadcom (AVGO)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)

View all positions for Capstone Investment Advisors

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
BlackRock
Vanguard Group
Deep Track Capital
State Street Corporation
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Federated Investors
Geode Capital Management
Morgan Stanley
Contrarius Investment Management
Casdin Capital
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Intellia Therapeutics